Enliven Therapeutics shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.5M | 123k | 20.47 |
| 2025-06-30 | $1.2M | 59k | 20.06 |
| 2025-03-31 | $466k | 24k | 19.68 |
| 2024-12-31 | $789k | 35k | 22.50 |